A role for c-myc in chemically induced renal-cell death

Molecular and Cellular Biology

Volumn 17, Issue 11, 1997, Pages 6755-6764

  Zhan, Yi ^a   Cleveland, John L ^b,c   Stevens, James L ^a  

^a Adirondack Biomedical Research Institute Inc   (United States)

^b ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

^c UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA DIFLUOROMETHYLARGININE; ORNITHINE DECARBOXYLASE;

APOPTOSIS; ARTICLE; CELL CULTURE; CELL DEATH; ENZYME ACTIVE SITE; GENETIC ANALYSIS; GENETIC TRANSFECTION; IMMUNOBLOTTING; KIDNEY CELL; NORTHERN BLOTTING; ONCOGENE C MYC; PLASMID; PRIORITY JOURNAL; PROMOTER REGION;

EID: 0030775018     PISSN: 02707306     EISSN: None     Source Type: Journal    
DOI: 10.1128/MCB.17.11.6755     Document Type: Article

References (75)

1. Askew, D. S., R. A. Ashmun, B. C. Simmons, and J. L. Cleveland. 1991. Constitutive c-myc expression in an IL-3-dependent myeloid cell line suppresses cell cycle arrest and accelerates apoptosis. Oncogene 6:1915-1922.
2. Ayer, D. E., L. Kretzner, and R. N. Eisenman. 1993. Mad: a heterodimeric partner for Max that antagonizes Myc transcriptional activity. Cell 72:211-222.
3. Ayer, D. E., Q. A. Lawrence, and R. N. Eisenman. 1995. Mad-Max transcriptional repression is mediated by ternary complex formation with mammalian homologs of yeast repressor Sin3. Cell 80:767-776.
4. Basu, A., and J. S. Cline. 1995. Oncogenic transformation alters cisplatin-induced apoptosis in rat embryo fibroblasts. Int. J. Cancer 63:597-603.
5. Beijersbergen, R. L., E. M. Hijmans, L. Shu, and R. Bernards. 1994. Interaction of c-Myc with the pRb-related protein p107 results in inhibition of c-Myc-mediated transactivation. EMBO J. 13:4080-4086.
6. Bello-Fernandez, C., G. Packham, and J. L. Cleveland. 1993. The ornithine decarboxylase gene is a transcriptional target of c-myc. Proc. Natl. Acad. Sci. USA 90:7804-7808.
7. Berberich, S. J., and M. D. Cole. 1992. Casein kinase II inhibits the DNA-binding activity of Max homodimers but not Myc/Max heterodimers. Genes Dev. 6:166-176.
8. Bernards, R. 1995. Flipping the Myc switch. Curr. Biol. 5:859-861.
9. Bissonnette, R. P., F. Echeverri, A. Mahboubi, and D. R. Green. 1992. Apoptotic cell death induced by c-myc is inhibited by bcl-2. Nature 359:552-554.
10. Blackwood, E. M., and R. N. Eisenman. 1991. Max: a helix-loop-helix zipper protein that forms a sequence-specific DNA-binding complex with Myc. Science 251:1211-1217.
11. Chen, Q., T. W. Jones, P. C. Brown, and J. L. Stevens. 1990. The mechanism of cysteine conjugate cytotoxicity in renal epithelial cells. Covalent binding leads to thiol depletion and lipid peroxidation. J. Biol. Chem. 265:21603-21611.
12. Cherney, B. W., K. Bhatia, and G. Tosato. 1994. A role for deregulated c-Myc expression in apoptosis of Epstein-Barr virus-immortalized B cells. Proc. Natl. Acad. Sci. USA 91:12967-12971.
13. Cowley, B. D., L. J. Chadwick, J. J. Grantham, and J. P. Calvet. 1989. Sequential protooncogene expression in regenerating kidney following acute renal injury. J. Biol. Chem. 264:8389-8393.
14. Crawford, D., I. Zbinden, P. Amstad, and P. Cerutti. 1988. Oxidant stress induces the proto-oncogenes c-fos and c-myc in mouse epidermal cells. Oncogene 3:27-32.
15. Davidoff, A. N., and B. V. Mendelow. 1993. Puromycin-elicited c-myc mRNA superinduction precedes apoptosis in HL-60 leukaemic cells. Anticancer Res. 13:2257-2260.
16. Davis, R. H., D. R. Morris, and P. Coffino. 1992. Sequestered end products and enzyme regulation: the case of ornithine decarboxylase. Microbiol. Rev. 56:280-290.
17. Dekant, W., S. Vamvakas, M. Koob, A. Kochling, W. Kanhai, D. Muller, and D. Henschler. 1990. A mechanisms of haloalkene-induced renal carcinogenesis. Environ. Health Perspect. 88:107-110.
18. Evan, G. I., and T. D. Littlewood. 1993. The role of c-myc in cell growth. Curr. Opin. Genet. Dev. 3:44-49.
19. Evan, G. I., A. H. Wyllie, C. S. Gilbert, T. D. Littlewood, H. Land, M. Brooks, C. M. Waters, L. Z. Penn, and D. C. Hancock. 1992. Induction of apoptosis in fibroblasts by c-myc protein. Cell 69:119-128.
20. Fanidi, A., E. A. Harrington, and G. I. Evan. 1992. Cooperative interaction between c-myc and bcl-2 proto-oncogenes. Nature 359:554-556.
21. Galaktionov, K., X. Chen, and D. Beach. 1996. Cdc25 cell-cycle phosphatase as a target of c-myc. Nature 382:511-517.
22. Green, T., and J. Odum. 1985. Structure/activity studies of the nephrotoxic and mutagenic action of cysteine conjugates of chloro-and fluoroalkenes. Chem. Biol. Interact. 54:15-31.
23. Gu, W., K. Bhatia, I. T. Magrath, C. V. Dang, and R. Dalla-Favera. 1994. Binding and suppression of the Myc transcriptional activation domain by p107. Science 264:251-254.
24. Gu, W., K. Cechova, V. Tassi, and R. Dalla-Favera. 1993. Opposite regulation of gene transcription and cell proliferation by c-Myc and Max. Proc. Natl. Acad. Sci. USA 90:2935-2939.
25. Hahn, S. R., M. Dixit, R. C. Sears, and L. Sealy. 1994. The alternatively initiated c-Myc proteins differentially regulate transcription through a non-canonical DNA-binding site. Genes Dev. 8:2441-2452.
26. Halleck, M. M., N. J. Holbrook, J. Skinner, H. Liu, and J. L. Stevens. 1997. The molecular response to reductive stress in the renal epithelial cell line LLC-PK1: coordinate transcriptional regulation of gadd153 and grp78 genes by thiols. Cell Stress Chaperones 2:31-40.
27. Harrington, E. A., M. R. Bennett, A. Fanidi, and G. I. Evan. 1994. c-Myc-induced apoptosis in fibroblasts is inhibited by specific cytokines. EMBO J. 13:3286-3295.
28. Hayden, P. J., and J. L. Stevens. 1990. Cysteine conjugate toxicity, metabolism, and binding to macromolecules in isolated rat kidney mitochondria. Mol. Pharmacol. 37:468-476.
29. Hermeking, H., and D. Eick. 1994. Mediation of c-Myc-induced apoptosis by p53. Science 265:2091-2093.
30. Hockenbery, D., G. Nunez, C. Milliman, R. D. Schreiber, and S. J. Korsmeyer. 1990. Bcl-2 is an inner mitochondrial membrane protein that blocks programmed cell death. Nature 348:334-336.
31. Hurlin, P. J., C. Queva, P. J. Koskinen, E. Steingrimsson, D. E. Ayer, N. G. Copeland, N. A. Jenkins, and R. N. Eisenman. 1995. Mad3 and Mad4: novel Max-interacting transcriptional repressors that suppress c-myc dependent transformation and are expressed during neural and epidermal differentiation. EMBO J. 14:5646-5659.
32. Janicke, R., F. H. H. Lee, and A. G. Porter. 1994. Nuclear Myc plays an important role in the cytotoxicity of tumor necrosis factor alpha in tumor cells. Mol. Cell. Biol. 14:5661-5670.
33. Kang, Y., R. Cortina, and R. R. Perry. 1996. Role of c-myc in tamoxifen-induced apoptosis estrogen-independent breast cancer cells. J. Natl. Cancer Inst. 88:279-284.
34. Kato, G. J., J. Barrett, M. Villa-Garcia, and C. V. Dang. 1990. An amino-terminal c-myc domain required for neoplastic transformation activates transcription. Mol. Cell. Biol. 10:5914-5920.
35. Kato, G. J., W. M. Lee, L. L. Chen, and C. V. Dang. 1992. Max: functional domains and interaction with c-Myc. Genes Dev. 6:81-92.
36. Klefstrom, J., I. Vastrik, E. Saksela, J. Valle, M. Eilers, and K. Alitalo. 1994. c-Myc induces cellular susceptibility to the cytotoxic action of TNF-alpha. EMBO J. 13:5442-5450.
37. Kretzner, L., E. M. Blackwood, and R. N. Eisenman. 1992. Myc and Max proteins possess distinct transcriptional activities. Nature 359:426-429.
38. Littlewood, T. D., D. C. Hancock, P. S. Danielian, M. G. Parker, and G. I. Evan. 1995. A modified oestrogen receptor ligand-binding domain as an improved switch for the regulation of heterologous proteins. Nucleic Acids Res. 23:1686-1690.
39. 38a. Liu, H., and J. L. Stevens. Unpublished data.
40. Lotem, J., and L. Sachs. 1993. Regulation by bcl-2, c-myc, and p53 of susceptibility to induction of apoptosis by heat shock and cancer chemotherapy compounds in differentiation-competent and differentiation-defective myeloid leukemic Cells. Cell Growth Differ. 4:41-47.
41. Lotem, J., and L. Sachs. 1995. A mutant p53 antagonizes the deregulated c-myc-mediated enhancement of apoptosis and decrease in leukemogenicity. Proc. Natl. Acad. Sci. USA 92:9672-9676.
42. Lowe, S. W., H. E. Ruley, T. Jacks, and D. E. Housman. 1993. p53-dependent apoptosis modulates the cytotoxicity of anticancer agents. Cell 74:957-967.
43. Majno, G., and I. Joris. 1995. Apoptosis, oncosis and necrosis. An overview of cell death. Am. J. Pathol. 146:3-15.
44. 2+] induction of c-fos, c-jun and c-myc mRNA in rat PTE after oxidative stress. FASEB J. 6:919-924.
45. Marcu, K. B., S. A. Bossone, and A. J. Patel. 1992. myc function and regulation. Annu. Rev. Biochem. 61:809-860.
46. Matsuoka, M., and K. M. Call. 1995. Cadmium-induced expression of immediate early genes in LLC-PK1 cells. Kidney Int. 48:383-389.
47. McCarthy, N. J., M. K. B. Whyte, C. S. Gilbert, and G. I. Evan. 1997. Inhibition of Ced-3/ICE-related proteases does not prevent cell death induced by oncogenes. DNA damage, or the Bcl-2 homologue Bak. J. Cell Biol. 136:215-227.
48. Nunez, G., L. London, D. Hockenberry, M. Alexander, J. P. McKearn, and S. J. Korsmeyer. 1990. Deregulated bcl-2 gene expression selectively prolongs survival of growth factor-deprived hemopoietic cell lines. J. Immunol. 144:3602-3610.
49. Packham, G., R. A. Ashmun, and J. L. Cleveland. 1996. Cytokines suppress apoptosis independent of increases in reactive oxygen levels. J. Immunol. 156:2792-2800.
50. Packham, G., and J. L. Cleveland. 1994. Ornithine decarboxylase is a mediator of c-Myc-induced apoptosis. Mol. Cell. Biol. 14:5741-5747.
51. Packham, G., and J. L. Cleveland. 1995. c-Myc and apoptosis. Biochim. Biophys. Acta 1242:11-28.
52. Packham, G., and J. L. Cleveland. Induction of ornithine decarboxylase by IL-3 is mediated by sequential c-Myc-independent and c-Myc dependent pathways. Oncogene, in press.
53. Packham, G., C. W. Porter, and J. L. Cleveland. 1996. c-Myc induces apoptosis and cell cycle progression by separable, yet overlapping, pathways. Oncogene 13:461-469.
54. Pena, A., C. D. Reddy, S. J. Wu, N. J. Hickok, E. P. Reddy, G. Yumet, D. R. Soprano, and K. J. Soprano. 1993. Regulation of human ornithine decarboxylase expression by the c-Myc-Max protein complex. J. Biol. Chem. 268: 27277-27285.
55. Reisman, D., N. B. Elkind, B. Roy, J. Beamon, and V. Rotter. 1993. c-Myc trans-activates the p53 promoter through a required downstream CACGTG motif. Cell Growth Differ. 4:57-65.
56. Sakamuro, D., V. Eviner, K. J. Elliott, L. Showe, E. White, and G. C. Prendergast. 1995. c-Myc induces apoptosis in epithelial cells by both p53-dependent and p53-independent mechanisms. Oncogene 11:2411-2418.
57. Schreiber-Agus, N., L. Chin, K. Chen, R. Torres, G. Rao, P. Guida, A. I. Skoultchi, and R. A. DePinho. 1995. An amino-terminal domain of Mxi1 mediates anti-myc oncogenic activity and interacts with a homolog of the yeast transcriptional repressor SIN3. Cell 80:777-786.
58. Sentman, C. L., J. R. Shutter, D. Hockenberry, O. Kanagawa, and S. J. Korsmeyer. 1991. bcl-2 inhibits multiple forms of apoptosis but not negative selection in thymocytes. Cell 67:879-888.
59. Shi, Y., J. M. Glynn, L. J. Guilbert, T. G. Cotter, R. P. Bissonnette, and D. R. Green. 1992. Role for c-myc in activation-induced apoptotic cell death in T cell hybridomas. Science 257:212-214.
60. Shibanuma, M., T. Kuroki, and K. Nose. 1990. Stimulation by hydrogen peroxide of DNA synthesis, competence family gene expression and phosphorylation of a specific protein in quiescent Balb/3T3 cells. Oncogene 5:1025-1032.
61. Stevens, J., P. Hayden, and G. Taylor. 1986. The role of glutathione conjugate metabolism and cysteine conjugate beta-lyase in the mechanism of S-cysteine conjugate toxicity in LLC-PK1 cells. J. Biol. Chem. 261:3325-3332.
62. 2+-Induced c-myc messenger RNA accumulation in NRK-49F cells is blocked by the protein kinase inhibitor H7 but not by HA1004, indicating that protein kinase C is a mediator of the response. Toxicology 81:155-164.
63. Tsujimoto, Y. 1989. Stress-resistance conferred by high level bcl-2 protein in human B lymphoblastoid cell. Oncogene 4:1331-1336.
64. Vamvakas, S., and U. Koster. 1993. The nephrotoxin dichlorovinylcysteine induces expression of the protooncogenes c-fos and c-myc in LLC-PK(1) cells - a comparative investigation with growth factors and 12-O-tetradecanoylphorbolacetate. Cell Biol. Toxicol. 9:1-13.
65. van de Water, B., M. Kruidering, and J. F. Nagelkerke. 1996. Role of F-actin damage and cell detachment in apoptotic cell death of cultured proximal tubular cells. Am. J. Physiol. 270:F593-F603.
66. van de Water, B., J. P. Zoeteweij, H. J. G. M. de Bont, G. J. Mulder, and J. F. Nagelkerke. 1994. Role of mitochondrial calcium in the oxidative stress-induced dissipation of the mitochondrial membrane potential: studies in isolated proximal tubular cells using the nephrotoxin 1,2-dichlorovinyl-cysteine. J. Biol. Chem. 269:14546-14552.
67. Vaux, D. L., S. Cory, and J. M. Adams. 1988. Bcl-2 gene promotes haemopoietic cell survival and cooperates with c-myc to immortalize pre-B cells. Nature 335:440-442.
68. Wagner, A. J., J. M. Kokontis, and N. Hay. 1994. Myc-mediated apoptosis requires wild-type p53 in a manner independent of cell cycle arrest and the ability of p53 to induce p21waf1/cip1. Genes Dev. 8:2817-2830.
69. Wagner, A. J., C. Meyers, L. A. Laimins, and N. Hay. 1993. c-Myc induces the expression and activity of ornithine decarboxylase. Cell Growth Differ. 4:879-883.
70. Wagner, A. J., M. B. Small, and N. Hay. 1993. Myc-Mediated apoptosis is blocked by ectopic expression of Bcl-2. Mol. Cell Biol. 13:2432-2440.
71. Weiss, J. M., K. J. Lembach, and R. J. Boucek. 1981. A comparison of ornithine decarboxylase from normal and SV40-transformed 3T3 mouse fibroblasts. Biochem. J. 194:229-239.
72. Yu, K., Q. Chen, H. Liu, Y. Zhan, and J. L. Stevens. 1994. Signaling the molecular stress response to nephrotoxic and mutagenic cysteine conjugates: differential roles for protein synthesis and calcium in the induction of c-fos and c-myc mRNA in LLC-PK1 cells. J. Cell Physiol. 161:303-311.
73. Zervos, A. S., J. Gyuris, and R. Brent. 1993. Mxi1, a protein that specifically interacts with Max to bind Myc-Max recognition sites. Cell 72:223-232.
74. Zhan, Y., and J. L. Stevens. Unpublished results.
75. Zhan, Y., B. van de Water, and J. L. Stevens. Unpublished results.